Try a new search

Format these results:

Searched for:



Total Results:


An international validation of knowledge-based planning [Meeting Abstract]

Babier, A; Zhang, B; Mahmood, R; Alves, V G L; Barragan, Montero A; Beaudry, J; Cardenas, C; Chang, Y; Chen, Z; Chun, J; Eraso, H; Faustmann, E; Gaj, S; Gay, S; Gronberg, M; He, J; Heilemann, G; Hira, S; Huang, Y; Ji, F; Jiang, D; Jimenez, Giraldo J; Lee, H; Lian, J; Liu, K; Liu, S; Marixa, K; Marrugo, J; Miki, K; Netherton, T; Nguyen, D; Nourzadeh, H; Osman, A; Peng, Z; Quinto, Munoz J; Ramsl, C; Rhee, D; Rodriguez, Arciniegas J; Shan, H; Siebers, J V; Soomro, M H; Sun, K; Usuga, Hoyos A; Valderrama, C; Verbeek, R; Wang, E; Willems, S; Wu, Q; Xu, X; Yang, S; Yuan, L; Zhu, S; Zimmermann, L; Moore, K L; Purdie, T G; McNiven, A L; Chan, T C Y
Purpose: To carry out a large international validation of how dose prediction quality translates to plan quality in a radiotherapy knowledge-based planning (KBP) process.
Method(s): We collected dose predictions for head-and-neck cancer radiotherapy from 21 different research groups internationally who participated in the OpenKBP Grand Challenge. Each research group used the same training dataset (n=200) and validation dataset (n=40) to develop their methods. These methods predicted dose on a testing dataset (n=100), and those 2100 unique dose predictions were input to a previously published plan optimization method to generate 2100 treatment plans. The predictions and plans were compared to the ground truth dose via: (1)error, the mean absolute voxel-by-voxel difference in dose; and (2) quality, the mean and maximum deviation across 23 dose-volume histogram (DVH) criteria.
Result(s): The range in median prediction error among the top 20 methods was 2.3Gy to 12.0Gy, which was 6.8Gy wider than the range in median plan error of 2.1Gy to 5.0Gy. One method also achieved significantly lower prediction error (P<0.05; one-sided Wilcoxon test) than all the other methods, however, it generated plans with error that was not significantly lower than 28.6% of the other methods. Additionally, predicted dose was consistently lower quality than plan dose. Half (n=1050) of all predictions and plans had an average deviation that was 0.1Gy worse and 0.8Gy better than the ground truth dose, respectively. Similarly, half of all predictions had a maximum deviation that was 3.7Gy worse than the ground truth dose, which was 1.0Gy worse than half of all plans.
Conclusion(s): Many dose prediction methods can achieve low error, however, optimization often improves upon the predictions and eliminates significant differences between prediction methods. Thus, it is critical that we improve the optimization stage in KBP to get better utility out of the existing high-quality dose prediction methods
ISSN: 0094-2405
CID: 4986252

A novel L23-related gene 40 kb downstream of the imprinted H19 gene is biallelically expressed in mid-fetal and adult human tissues

Tsang, P; Gilles, F; Yuan, L; Kuo, Y H; Lupu, F; Samara, G; Moosikasuwan, J; Goye, A; Zelenetz, A D; Selleri, L
The closely linked IGF2 and H19 genes on human chromosome 11p15.5 are monoallelically expressed as a result of genomic imprinting and show altered expression in Wilms' tumors (WTs). To map regional imprinting we have sought to isolate additional human genes close to IGF2/H19 and to characterize their allelic expression patterns. Here we report a novel gene, provisionally named L23MRP [L23 (mitochondrial)-related protein], which is oriented 'tail-to-tail' with H19 and is transcribed to within 40 kb of the last H19 exon. L23MRP is expressed biallelically in many mid-fetal and adult human tissues. This gene is also expressed at normal levels in WTs which have lost expression of H19 either via loss of the maternal chromosome 11p15.5 or via an epigenetic pathway involving site-specific DNA hypermethylation. These data indicate that, at least in post-embryonic stages, L23MRP is functionally insulated from the IGF2/H19 imprinted domain.
PMID: 8541832
ISSN: 0964-6906
CID: 5515852